Originally published January 16 2006
Center to provide training for locals in Brazil and Zimbabwe to fight rampant diseases
by Mike Adams, the Health Ranger, NaturalNews Editor
As part of the National Institutes of Health (NIH), the Fogarty International Center (FIC) has granted funding to institutions in Brazil and Zimbabwe that will provide training to help combat HIV and tuberculosis.
The Fogarty International Center (FIC), part of the National Institutes of Health (NIH), today announced it funded institutions in Brazil and Zimbabwe, along with partner institutions in the United States, to establish research training programs to improve in-country capacity to fight AIDS and TB.
The awards were made through FIC's International Clinical, Operational, and Health Services Research Training Award Program for AIDS and Tuberculosis (ICOHRTA-AIDS/TB).
One group of partner awardees includes Dr. Jose R. Lapa e Silva of the Federal University of Rio de Janeiro (Rio de Janeiro, Brazil) and Dr. Richard Chaisson of Johns Hopkins University (Baltimore, MD).
They will establish a research training program at the Federal University of Rio de Janeiro to develop a new cadre of clinical and health service researchers who will contribute toward controlling TB and TB-HIV co-infection in Brazil.
FIC will add $6 million for these awards to the previous total of $12 million made by FIC and its NIH partners and the United States Agency for International Development (USAID).
"As treatment drugs become more available, a pressing need will be to monitor and evaluate their effectiveness in the population.
FIC developed ICOHRTA-AIDS/TB in collaboration with NIH's National Institute of Allergy and Infectious Diseases, National Institute on Alcohol Abuse and Alcoholism, National Cancer Institute, National Institute of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Office of AIDS Research, and Office of Research on Women's Health, Centers for Disease Control and Prevention, and USAID.
It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml